English

SOLENO THERAPEUTICS INC

EDGAR

CAPN Quarterly report (10-Q) · filed 2026-05-07

140 filing records in this dataset, filed from 2014-06-10 to 2026-05-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1 thousand USD

2017 Q2 · USD

Exact inputs and evidence

Revenue: 1000 USD Source

Operating margin

-296,800%

2017 Q2 · %

Exact inputs and evidence

Operating Income: -2968000 USD Source
Revenue: 1000 USD Source

Operating cash flow

-2.99 million USD

2017 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -5175000 USD Source
Operating Cash Flow: -2183000 USD Source

Cash and cash equivalents: 133 million USD 2026-03-31 Source
Exact value

133000000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 51.7 million shares 2026-03-31 Source
Exact value

51718149 shares

Reported share-count change

6.57% · 3.19 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

48527469 shares · 2025-03-31· Source
51718149 shares · 2026-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

879 thousand USD

2016-07-01 – 2017-06-30

Exact inputs and evidence

Revenue: 329000 USD · 2016-07-01 – 2016-09-30 Source
Revenue: 1450788 USD · 2016-01-01 – 2016-12-31 Source
Revenue: 1167000 USD · 2016-01-01 – 2016-09-30 Source
Revenue: 265000 USD · 2017-01-01 – 2017-03-31 Source
Revenue: 1000 USD · 2017-04-01 – 2017-06-30 Source

Net income

96 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence

Net income: -4708000 USD · 2025-04-01 – 2025-06-30 Source
Net income: 26013000 USD · 2025-07-01 – 2025-09-30 Source
Net income: 20890000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -22468000 USD · 2025-01-01 – 2025-09-30 Source
Net income: 31378000 USD · 2026-01-01 – 2026-03-31 Source

Operating cash flow

106 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence

Operating cash flow: -45400000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -32752000 USD · 2025-01-01 – 2025-03-31 Source
Operating cash flow: -1900000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -45400000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 46800000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -1900000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 26000000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

108 thousand USD

2025-04-01 – 2026-03-31

Exact inputs and evidence

Capital expenditure: 14000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 5000 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 15000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 14000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 73000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 15000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 40000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

105 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence

Operating cash flow: -45400000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -32752000 USD · 2025-01-01 – 2025-03-31 Source
Operating cash flow: -1900000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -45400000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: 46800000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -1900000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 26000000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 14000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 5000 USD · 2025-01-01 – 2025-03-31 Source
Capital expenditure: 15000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 14000 USD · 2025-01-01 – 2025-06-30 Source
Capital expenditure: 73000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 15000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 40000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-05-07.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2016-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 196.74 million

Prior period

−USD 175.85 million

2024-01-01 – 2024-12-31
Current period

USD 20.89 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

20890000 − -175850000 = 196740000 USD

-175850000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
20890000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SOLENO THERAPEUTICS INC · 2025-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Year-over-year change in Net income: 196740000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 20890000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#3816578 Filing: 000119312526071808 Input fundies:NetIncome: -175850000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#3818298 Filing: 000119312526071808
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 115.9 million

Prior period

−USD 69.1 million

2024-01-01 – 2024-12-31
Current period

USD 46.8 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

46800000 − -69096000 = 115896000 USD

-69096000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
46800000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SOLENO THERAPEUTICS INC · 2025-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Year-over-year change in Operating cash flow: 115896000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 46800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#2085895 Filing: 000119312526071808 Input fundies:OperatingCashFlow: -69096000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1931408 Filing: 000119312526071808
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-66.5%

Prior period

USD 218,000

2024-01-01 – 2024-12-31
Current period

USD 73,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

73000 − 218000 = -145000 USD

218000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
73000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SOLENO THERAPEUTICS INC · 2025-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Year-over-year change in Capital expenditure: -145000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 73000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1939103 Filing: 000119312526071808 Input fundies:CapitalExpenditure: 218000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1940866 Filing: 000119312526071808
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 1.45 million 100% of revenue
Operating costs Derived USD 9.77 million 674% of revenue
Operating income −USD 8.32 million −574% of revenue
Tax, interest and other Derived USD 3.74 million 258% of revenue
Net income −USD 12.07 million −832% of revenue

Cash

Operating cash flow −USD 13.5 million −930% of revenue
Capital expenditure USD 14,795 1% of revenue
Free cash flow Derived −USD 13.51 million −931% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 674% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	1450788	9774905 Derived	-8324117	3741097 Derived	-12065214	-13512775 Derived	Source 2016-01-01 – 2016-12-31: 1450788 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -8324117 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -12065214 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -13497980 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 14795 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.5M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	607472	Revenue: 607472 Open source
20162016-12-31	Revenue	1450788	Revenue: 1450788 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

138.8% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 607472 Open source
20162016-12-31	Year over year	138.8%	Revenue: 1450788 Open source Revenue: 607472 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -573.8% 2016

Net margin -831.6% 2016

Free cash flow margin -931.4% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-986.3%	Operating Income: -5991266 Open source Revenue: 607472 Open source
20162016-12-31	Operating margin	-573.8%	Operating Income: -8324117 Open source Revenue: 1450788 Open source
20152015-12-31	Net margin	-2,618.8%	Net Income: -15908546 Open source Revenue: 607472 Open source
20162016-12-31	Net margin	-831.6%	Net Income: -12065214 Open source Revenue: 1450788 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 607472 Open source
20162016-12-31	Free cash flow margin	-931.4%	Revenue: 1450788 Open source Operating Cash Flow: -13497980 Open source Capital Expenditure: 14795 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.5M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	Not reported	No source recorded
20162016-12-31	Operating cash flow	-13497980	Operating Cash Flow: -13497980 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13.5M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	No source recorded
20162016-12-31	Free cash flow	-13512775	Operating Cash Flow: -13497980 Open source Capital Expenditure: 14795 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

38.3% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	60.7%	Total Liabilities: 4977379 Open source Total Assets: 8201195 Open source
20162016-12-31	Liabilities / assets	38.3%	Total Liabilities: 2129655 Open source Total Assets: 5564852 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.23× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	2.01×	Current Assets: 6404300 Open source Current Liabilities: 3192735 Open source
20162016-12-31	Current assets / current liabilities	2.23×	Current Assets: 3801294 Open source Current Liabilities: 1707378 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 12.07 million Exact value Exact value: -12065214 USD 2016-01-01 – 2016-12-31: -12065214 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2016-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -12065214 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12065214 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312518104048/slno-20171231.xml#938668 Filing: 000119312518104048 The citation records this snapshot. The page link may show a newer release later.	−USD 13.5 million Exact value Exact value: -13497980 USD 2016-01-01 – 2016-12-31: -13497980 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2016-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -13497980 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13497980 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312518104048/slno-20171231.xml#938400 Filing: 000119312518104048 The citation records this snapshot. The page link may show a newer release later.	USD 14,795 Exact value Exact value: 14795 USD 2016-01-01 – 2016-12-31: 14795 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2016-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 14795 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14795 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312518104048/slno-20171231.xml#940288 Filing: 000119312518104048 The citation records this snapshot. The page link may show a newer release later.	−USD 13.51 million Calculation and evidence -13497980 − 14795 USD Exact free cash flow: -13512775 USD 2016-01-01 – 2016-12-31: -13497980 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 14795 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2016-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -13512775 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13497980 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312518104048/slno-20171231.xml#938400 Filing: 000119312518104048 Input fundies:CapitalExpenditure: 14795 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312518104048/slno-20171231.xml#940288 Filing: 000119312518104048 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 15.39 million Exact value Exact value: -15385000 USD 2017-01-01 – 2017-12-31: -15385000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2017-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -15385000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15385000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459019010146/slno-20190223.xml#174652 Filing: 000156459019010146 The citation records this snapshot. The page link may show a newer release later.	−USD 9.95 million Exact value Exact value: -9950000 USD 2017-01-01 – 2017-12-31: -9950000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2017-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -9950000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9950000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459019010146/slno-20190223.xml#200902 Filing: 000156459019010146 The citation records this snapshot. The page link may show a newer release later.	USD 2,000 Exact value Exact value: 2000 USD 2017-01-01 – 2017-12-31: 2000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2017-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 2000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459019010146/slno-20190223.xml#201721 Filing: 000156459019010146 The citation records this snapshot. The page link may show a newer release later.	−USD 9.95 million Calculation and evidence -9950000 − 2000 USD Exact free cash flow: -9952000 USD 2017-01-01 – 2017-12-31: -9950000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 2000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2017-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -9952000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9950000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459019010146/slno-20190223.xml#200902 Filing: 000156459019010146 Input fundies:CapitalExpenditure: 2000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459019010146/slno-20190223.xml#201721 Filing: 000156459019010146 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 13.34 million Exact value Exact value: -13335000 USD 2018-01-01 – 2018-12-31: -13335000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2018-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -13335000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13335000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459020008705/slno-20191231.xml#161302 Filing: 000156459020008705 The citation records this snapshot. The page link may show a newer release later.	−USD 11.68 million Exact value Exact value: -11683000 USD 2018-01-01 – 2018-12-31: -11683000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2018-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -11683000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11683000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459020008705/slno-20191231.xml#180751 Filing: 000156459020008705 The citation records this snapshot. The page link may show a newer release later.	USD 8,000 Exact value Exact value: 8000 USD 2018-01-01 – 2018-12-31: 8000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2018-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 8000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459020008705/slno-20191231.xml#181171 Filing: 000156459020008705 The citation records this snapshot. The page link may show a newer release later.	−USD 11.69 million Calculation and evidence -11683000 − 8000 USD Exact free cash flow: -11691000 USD 2018-01-01 – 2018-12-31: -11683000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 8000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2018-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -11691000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11683000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459020008705/slno-20191231.xml#180751 Filing: 000156459020008705 Input fundies:CapitalExpenditure: 8000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459020008705/slno-20191231.xml#181171 Filing: 000156459020008705 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 30.77 million Exact value Exact value: -30774000 USD 2019-01-01 – 2019-12-31: -30774000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2019-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -30774000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30774000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459021010569/slno-20201231.xml#139516 Filing: 000156459021010569 The citation records this snapshot. The page link may show a newer release later.	−USD 17.38 million Exact value Exact value: -17375000 USD 2019-01-01 – 2019-12-31: -17375000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2019-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -17375000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17375000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459021010569/slno-20201231.xml#153363 Filing: 000156459021010569 The citation records this snapshot. The page link may show a newer release later.	USD 21,000 Exact value Exact value: 21000 USD 2019-01-01 – 2019-12-31: 21000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2019-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 21000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459021010569/slno-20201231.xml#153782 Filing: 000156459021010569 The citation records this snapshot. The page link may show a newer release later.	−USD 17.4 million Calculation and evidence -17375000 − 21000 USD Exact free cash flow: -17396000 USD 2019-01-01 – 2019-12-31: -17375000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 21000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2019-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -17396000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17375000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459021010569/slno-20201231.xml#153363 Filing: 000156459021010569 Input fundies:CapitalExpenditure: 21000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459021010569/slno-20201231.xml#153782 Filing: 000156459021010569 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 24.64 million Exact value Exact value: -24639000 USD 2020-01-01 – 2020-12-31: -24639000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2020-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -24639000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24639000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459022013023/slno-10k_20211231.htm#1199518 Filing: 000156459022013023 The citation records this snapshot. The page link may show a newer release later.	−USD 25.22 million Exact value Exact value: -25224000 USD 2020-01-01 – 2020-12-31: -25224000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2020-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -25224000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25224000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459022013023/slno-10k_20211231.htm#1324983 Filing: 000156459022013023 The citation records this snapshot. The page link may show a newer release later.	USD 7,000 Exact value Exact value: 7000 USD 2020-01-01 – 2020-12-31: 7000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2020-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459022013023/slno-10k_20211231.htm#1332868 Filing: 000156459022013023 The citation records this snapshot. The page link may show a newer release later.	−USD 25.23 million Calculation and evidence -25224000 − 7000 USD Exact free cash flow: -25231000 USD 2020-01-01 – 2020-12-31: -25224000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 7000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2020-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -25231000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25224000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459022013023/slno-10k_20211231.htm#1324983 Filing: 000156459022013023 Input fundies:CapitalExpenditure: 7000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000156459022013023/slno-10k_20211231.htm#1332868 Filing: 000156459022013023 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 30.91 million Exact value Exact value: -30910000 USD 2021-01-01 – 2021-12-31: -30910000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2021-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -30910000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30910000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017023009211/slno-20221231.htm#1344256 Filing: 000095017023009211 The citation records this snapshot. The page link may show a newer release later.	−USD 27.77 million Exact value Exact value: -27770000 USD 2021-01-01 – 2021-12-31: -27770000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2021-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -27770000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27770000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017023009211/slno-20221231.htm#1524109 Filing: 000095017023009211 The citation records this snapshot. The page link may show a newer release later.	USD 22,000 Exact value Exact value: 22000 USD 2021-01-01 – 2021-12-31: 22000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2021-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 22000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017023009211/slno-20221231.htm#1532211 Filing: 000095017023009211 The citation records this snapshot. The page link may show a newer release later.	−USD 27.79 million Calculation and evidence -27770000 − 22000 USD Exact free cash flow: -27792000 USD 2021-01-01 – 2021-12-31: -27770000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 22000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2021-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -27792000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27770000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017023009211/slno-20221231.htm#1524109 Filing: 000095017023009211 Input fundies:CapitalExpenditure: 22000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017023009211/slno-20221231.htm#1532211 Filing: 000095017023009211 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 24.07 million Exact value Exact value: -24067000 USD 2022-01-01 – 2022-12-31: -24067000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2022-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -24067000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24067000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017025029545/slno-20241231.htm#3108219 Filing: 000095017025029545 The citation records this snapshot. The page link may show a newer release later.	−USD 20.78 million Exact value Exact value: -20781000 USD 2022-01-01 – 2022-12-31: -20781000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2022-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -20781000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20781000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017025029545/slno-20241231.htm#1778580 Filing: 000095017025029545 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 2022-01-01 – 2022-12-31: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2022-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017025029545/slno-20241231.htm#1787159 Filing: 000095017025029545 The citation records this snapshot. The page link may show a newer release later.	−USD 20.79 million Calculation and evidence -20781000 − 13000 USD Exact free cash flow: -20794000 USD 2022-01-01 – 2022-12-31: -20781000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2022-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -20794000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20781000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017025029545/slno-20241231.htm#1778580 Filing: 000095017025029545 Input fundies:CapitalExpenditure: 13000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000095017025029545/slno-20241231.htm#1787159 Filing: 000095017025029545 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 38.99 million Exact value Exact value: -38988000 USD 2023-01-01 – 2023-12-31: -38988000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2023-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -38988000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -38988000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#3820037 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	−USD 24.94 million Exact value Exact value: -24940000 USD 2023-01-01 – 2023-12-31: -24940000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2023-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -24940000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24940000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1933288 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2023-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1942489 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	−USD 24.94 million Calculation and evidence -24940000 − 0 USD Exact free cash flow: -24940000 USD 2023-01-01 – 2023-12-31: -24940000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2023-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -24940000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24940000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1933288 Filing: 000119312526071808 Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1942489 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 175.85 million Exact value Exact value: -175850000 USD 2024-01-01 – 2024-12-31: -175850000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2024-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: -175850000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -175850000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#3818298 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	−USD 69.1 million Exact value Exact value: -69096000 USD 2024-01-01 – 2024-12-31: -69096000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2024-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: -69096000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -69096000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1931408 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	USD 218,000 Exact value Exact value: 218000 USD 2024-01-01 – 2024-12-31: 218000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2024-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 218000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 218000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1940866 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	−USD 69.31 million Calculation and evidence -69096000 − 218000 USD Exact free cash flow: -69314000 USD 2024-01-01 – 2024-12-31: -69096000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 218000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2024-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: -69314000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -69096000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1931408 Filing: 000119312526071808 Input fundies:CapitalExpenditure: 218000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1940866 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 20.89 million Exact value Exact value: 20890000 USD 2025-01-01 – 2025-12-31: 20890000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLENO THERAPEUTICS INC · 2025-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Net Income: 20890000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 20890000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#3816578 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	USD 46.8 million Exact value Exact value: 46800000 USD 2025-01-01 – 2025-12-31: 46800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLENO THERAPEUTICS INC · 2025-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Operating Cash Flow: 46800000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 46800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#2085895 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	USD 73,000 Exact value Exact value: 73000 USD 2025-01-01 – 2025-12-31: 73000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLENO THERAPEUTICS INC · 2025-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Capital Expenditure: 73000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 73000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1939103 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.	USD 46.73 million Calculation and evidence 46800000 − 73000 USD Exact free cash flow: 46727000 USD 2025-01-01 – 2025-12-31: 46800000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 73000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLENO THERAPEUTICS INC · 2025-12-31 SOLENO THERAPEUTICS INC (edgar:1484565) Free cash flow: 46727000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:30:04Z Snapshot: 4930b17c628f28571d0be7327d0b5b884d46fb4a90a6f856025f3ede977872d4 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1484565?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 46800000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#2085895 Filing: 000119312526071808 Input fundies:CapitalExpenditure: 73000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1484565/000119312526071808/slno-20251231.htm#1939103 Filing: 000119312526071808 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

140 filings · 2,692 latest values · 2,692 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001484565, 1484565, CAPN, SLNO, edgar:1484565

Also known as Capnia, Inc., SOLENO THERAPEUTICS INC

SOLENO THERAPEUTICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation